
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Jun 23
Feb 23
Innoplexus wins Horizon Interactive Gold Award for Curia App
Read MoreData are not the new gold – but the ability to put them together in a relevant and analyzable way is Innoplexus has contributed to big data and Artificial Intelligence (AI) projects in pharma R&D. In this paper we share our point of view on the impact of AI enabled technologies on R&D that can …
Impact of AI and Digitalization on R&D in Biopharmaceutical Industry Read More »
Artificial intelligence, or AI, is gaining more attention in the pharma space these days. At one time evoking images from futuristic science fiction, it now plays a significant role in smartphones, cars, search engines, and financial transactions. But what, exactly, is artificial intelligence? It is a set of very specialized algorithms trained to solve very …
Current approaches to drug development that rely solely on identifying statistical differences between healthy and diseased patients to pinpoint biomarkers, molecular targets, or suitable drugs often fail to provide biologically useful results. While these differences can help predict which patients are likely to have misregulation of a particular gene, receptor, or protein, the majority of …
How AI Makes Identifying Biomarkers More Accurate and Efficient Read More »